Biochimpharm Completed EUR 6 MLN Modernization Project At The Phage Manufacturing Facility
BM.GE
04.07.23 17:27
• 279
Biochimpharm has completed EUR 6 million modernization project at the historic phage manufacturing facility in Tbilisi, which dates back to 1934.
"We would like to express our heartfelt appreciation to our esteemed local and international partners (EBRD, European Union, ProCredit Bank, FAO, Enterprise Georgia and GITA), without whom this project would not have been possible. To honor their contributions, we proudly introduce the PHAGE AWARD, recognizing their outstanding commitment to fighting antimicrobial resistance and advancing phage technology.
In today's focus, we highlight the European Bank for Reconstruction and Development (EBRD)! We extend our sincere thanks to the European Bank for Reconstruction and Development, the EBRD Georgia team, and Catarina Bjorlin Hansen for their remarkable support in the fight against AMR and the development of phage therapy", - the company notes.
Biochimpharm is producing life-saving, phage-based novel antibiotics with European precision and quality. The company is making significant strides in combating AMR and propelling phage therapy.
